Rigel(US:RIGL) Prnewswireยท2025-02-25 13:05Core Viewpoint - Rigel Pharmaceuticals, Inc. will report its fourth quarter and full year 2024 financial results on March 4, 2025, followed by a live conference call to discuss the results and business updates [1]. Company Information - Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing novel therapies for patients with hematologic disorders and cancer, founded in 1996 and based in South San Francisco, California [3]. - The company is listed on Nasdaq under the ticker symbol RIGL [1]. Conference Call Details - The live conference call can be accessed by dialing 877-407-3088 for domestic participants and 201-389-0927 for international participants [2]. - The conference call will also be webcast live and available for replay for 90 days after the call on the company's website [2].